← 홈

프로그램 비교

타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일

현재 선택: 1 · 임상 갱신 필요 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV15행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
CGTStandard DatabasestalePhase 2
NKAEs (Expanded haploidentical natural killer cells, Expanded haploidentical natural killer cells (NKAEs))
Hospital Infantil Universitario Ni…·FRα
19 trials
Overview
Program
Expanded haploidentical natural killer cells (NKAEs)
Overview
Company
Hospital Infantil Universitario Niño Jesús, Madrid, Spain
Overview
Modality
CGT
Overview
Target
FRα
Overview
Indication
Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma
Overview
Phase
PHASE_2
Overview
Status
DISCONTINUED
Overview
Content status
Standard Database
Overview
Data Confidence
Data Confidence · Medium
Overview
Development Signal
Development Signal · Emerging
Overview
Approval status
Investigational
Toxicology
Major finding
NK cell adoptive transfer in acute myeloid leukemia: a systematic review and meta-analysis.. Acute myeloid leukemia (AML) remains associated with high relapse rates and poor long-term survival, particularly in refractory patients or those ineligible for hematopoietic stem cell transplantation (HSCT). Adoptive transfer of natural killer (NK) cells has emerged as a promising immunotherapeutic strate…
Toxicology
CRS
Reported
Clinical
Safety signal
NK cell adoptive transfer in acute myeloid leukemia: a systematic review and meta-analysis.. Acute myeloid leukemia (AML) remains associated with high relapse rates and poor long-term survival, particularly in refractory patients or those ineligible for hematopoietic stem cell transplantation (HSCT). Adoptive transfer of natural killer (NK) cells has emerged as a promising immunotherapeutic strate…
Clinical
Program phase
PHASE_2